The most important financial indicators for the company Oculus - Med S.r.l. - Unique Identification Number 7704364:
sales in 2023 was
295.047
euro, registering a net profit of
99.885
euro and having an average number of
3
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 5.4%, from 280.901 euro in the year 2022, to 295.047 euro in 2023.
The Net Profit increased by 2.307 euro, from 97.874 euro in 2022, to 99.885 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Oculus - Med S.r.l. - CUI 7704364
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
213.213
175.548
132.834
117.038
88.209
73.775
112.672
87.319
65.890
70.179
Current Assets
263.169
281.575
174.881
187.958
254.807
327.195
308.086
375.526
229.910
243.335
Inventories
23.697
18.905
21.395
15.982
16.675
18.365
17.213
19.652
21.143
22.576
Receivables
1.038
578
3.699
14.018
14.496
15.154
7.623
13.096
6.438
6.185
Cash
238.434
262.092
149.787
157.958
223.636
293.675
283.249
342.778
202.329
214.575
Shareholders Funds
371.306
375.346
260.345
280.725
321.586
378.091
410.303
448.946
284.278
303.079
Social Capital
223
225
223
219
215
211
207
202
203
202
Debts
105.076
82.134
48.037
24.895
21.429
22.879
10.455
14.061
11.685
10.517
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
243.335 euro in 2023 which includes Inventories of
22.576 euro, Receivables of
6.185 euro and cash availability of
214.575 euro.
The company's Equity was valued at
303.079 euro, while total Liabilities amounted to
10.517 euro.
Equity increased by 19.663 euro, from 284.278 euro in 2022, to 303.079 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Oculus - Med S.r.l.